0

Close
 
Upcoming Allied Market Research
2023
Medical Elastomers Market

Medical Elastomers Market

by Type (Thermoset, Thermoplastic, Others) and by Application (Medical Tubes, Catheters, Syringes, Gloves, Medical Bags, Implants, Other Applications): Global Opportunity Analysis and Industry Forecast, 2023-2032

MC : Advanced Materials
Report Code: A15521
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Medical Elastomers Market

Request Now !

Thermoset elastomers are common, but thermoplastic elastomers are also available. During curing, or vulcanizing, the long polymer chains crosslink. Temperature effects can also be seen in a polymer's demonstrated elasticity. Elastomers that have cooled to a glassy or crystalline phase have fewer mobile chains and, as a result, less elasticity than those that have been manipulated at temperatures above the polymer's glass transition temperature. Recent developments in the medical field have paved the way for breakthroughs in polymer technology. For applications that require flexibility or rubber-like elasticity, medical device manufacturers increasingly turn to thermoplastic elastomers, and they turn to Teknor Apex for high quality, regulatory-compliant TPEs with a proven record of accomplishment.

COVID-19 Impact analysis

COVID-19's unprecedented crisis in 2020 continues to have a visible and significant impact on the global workforce, industry, country, and economy. The pandemic has hampered the Medical Elastomers supply chain, particularly in terms of raw material for medical-grade elastomers. Polymer and reinforcing filler are used to make elastomers. Due to the pandemic, businesses were forced to close their doors, resulting in a shortage of raw materials. The export or import of elastomers or raw materials had to go through a strict sanitization process and had to stay at docks during the peak of the pandemic, causing a supply chain disruption that also hampered the growth of the industry. 

Top Impacting Factors

Medical elastomers have a variety of physical characteristics, including viscosity and a weak intermolecular force. It is used for a variety of things, including infusion solution bags, syringes, tubes, and various implants like heart valves and joints. Medical elastomers are designed to meet the demanding needs of the healthcare industry. Advancements in thermoplastic elastomer (TPE) processing technology, growing demand for medical products incorporating elastomers, increasing government support, and rising public awareness about improved healthcare facilities are all driving the global medical elastomers market.

Market Trends 

  • The thermoplastic elastomers (TPE) segment is the largest market shareholder in the medical elastomers market among the various types.
  • Many medical device companies are attempting to address new regulatory dynamics in advance, such as implementing strategic initiatives for phthalate-free patient environments in the U.S. and other parts of the world.
  • In applications where phthalate- or plasticizer-free materials are desired, TPEs are being considered as a replacement for PVC. IV therapy manufacturers are among the first in the medical device industry to switch from PVC to TPE materials on a global scale.
  • TPEs are also being used to replace thermoset rubbers (like silicone, polyisoprene, and butyl rubber) in elastomeric medical applications like septums, stoppers, and syringe plungers.
  • This trend of switching to TPE is gaining traction, and it is expected to fuel the global medical elastomers market's growth in the coming years.
  • A growth driver will be advancements in the thermoplastic elastomer processing industry, which will increase demand for medical elastomers. The market is expected to grow due to increased demand for safe and halogen-free polymers, as well as a shift in the medical industry toward health devices and externally communicating medical tools.
  • During the forecast period, rising awareness and adoption of high-quality healthcare products will also drive demand for medical elastomers. Some elastomers' biocompatibility concerns, combined with stringent regulatory requirements around the world, may limit the medical elastomers market's growth during the forecast period.
  • Growing latex allergies among surgeons, as well as a ban on powdered latex surgical gloves, may limit market growth over the forecast period. Today, medical-grade elastomers are also used to make implants and prosthetics, which take advantage of the material's flexibility to achieve specific results.
  • Dental implants and prosthetics are primarily used to fill cavities in the mouth or to replace them with a concrete solution, and the World Health Organization estimates that oral health issues affect nearly 3 billion people worldwide. A dental implant is an oral prosthetic in which the gum is opened and a prosthetic crown is placed in the cavity.
  • North America is the most important regional market. Because the United States is the world's largest hub for medical device manufacturing, there is a huge demand for medical elastomers.
  • The medical device industry in the United States is by far one of the most advanced in the country. An increasing geriatric population and a growing demand for medical facilities to treat chronic diseases have aided the sector’s growth.
  • The demand for medical elastomers has grown even more in North America as a result of medical tubing operations.
  • The large market size, combined with North America's rapid growth, has played a significant role in the global medical elastomers market's expansion.

Key Benefits of the Report

  • This study presents the analytical depiction of the medical elastomers market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the medical elastomers market share.
  • The current market is quantitatively analyzed to highlight the medical elastomers market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed medical elastomers market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions Answered in the Medical Elastomers Market Report

  • Who are the leading market players active in the medical elastomers market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What are medical elastomers?
  • What does medical elastomers allow organizations to achieve?
  • Which technologies combine to make medical elastomers critical organizational asset?
  • What are the current trends and predicted trends?

 Medical Elastomers Market Report Highlights

Aspects Details
By Type
  • Thermoset
  • Thermoplastic
  • Others
By Application
  • Medical Tubes
  • Catheters
  • Syringes
  • Gloves
  • Medical Bags
  • Implants
  • Other Applications
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (UK, Germany, France, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players RAUMEDIC AG, The Hygenic Corporation, HEXPOL AB, Foster Corporation, Trelleborg AB, Teknor Apex, Polyone Corporation, Kuraray Co., Ltd., RTP Company, Celanese Corporation, DSM, Dow, DuPont, Biomerics, Momentive Performance Materials Inc., KRATON CORPORATION, BASF SE
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: MEDICAL ELASTOMERS MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Thermoset

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Thermoplastic

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Others

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: MEDICAL ELASTOMERS MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Medical Tubes

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Catheters

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Syringes

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Gloves

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Medical Bags

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Implants

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Other Applications

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

  • CHAPTER 6: MEDICAL ELASTOMERS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Medical Elastomers Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Medical Elastomers Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Medical Elastomers Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Medical Elastomers Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Medical Elastomers Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Medical Elastomers Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Medical Elastomers Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Medical Elastomers Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Medical Elastomers Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Medical Elastomers Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Medical Elastomers Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Medical Elastomers Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Medical Elastomers Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Medical Elastomers Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Medical Elastomers Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Medical Elastomers Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Medical Elastomers Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Medical Elastomers Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Medical Elastomers Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Medical Elastomers Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Medical Elastomers Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Medical Elastomers Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Medical Elastomers Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Medical Elastomers Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Medical Elastomers Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Trelleborg AB

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Kuraray Co., Ltd.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Teknor Apex

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Momentive Performance Materials Inc.

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Celanese Corporation

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Polyone Corporation

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. KRATON CORPORATION

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. RAUMEDIC AG

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. HEXPOL AB

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Foster Corporation

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

    • 8.11. RTP Company

      • 8.11.1. Company Overview

      • 8.11.2. Key Executives

      • 8.11.3. Company Snapshot

      • 8.11.4. Operating Business Segments

      • 8.11.5. Product Portfolio

      • 8.11.6. Business Performance

      • 8.11.7. Key Strategic Moves and Developments

    • 8.12. The Hygenic Corporation

      • 8.12.1. Company Overview

      • 8.12.2. Key Executives

      • 8.12.3. Company Snapshot

      • 8.12.4. Operating Business Segments

      • 8.12.5. Product Portfolio

      • 8.12.6. Business Performance

      • 8.12.7. Key Strategic Moves and Developments

    • 8.13. Biomerics

      • 8.13.1. Company Overview

      • 8.13.2. Key Executives

      • 8.13.3. Company Snapshot

      • 8.13.4. Operating Business Segments

      • 8.13.5. Product Portfolio

      • 8.13.6. Business Performance

      • 8.13.7. Key Strategic Moves and Developments

    • 8.14. DSM

      • 8.14.1. Company Overview

      • 8.14.2. Key Executives

      • 8.14.3. Company Snapshot

      • 8.14.4. Operating Business Segments

      • 8.14.5. Product Portfolio

      • 8.14.6. Business Performance

      • 8.14.7. Key Strategic Moves and Developments

    • 8.15. BASF SE

      • 8.15.1. Company Overview

      • 8.15.2. Key Executives

      • 8.15.3. Company Snapshot

      • 8.15.4. Operating Business Segments

      • 8.15.5. Product Portfolio

      • 8.15.6. Business Performance

      • 8.15.7. Key Strategic Moves and Developments

    • 8.16. Dow

      • 8.16.1. Company Overview

      • 8.16.2. Key Executives

      • 8.16.3. Company Snapshot

      • 8.16.4. Operating Business Segments

      • 8.16.5. Product Portfolio

      • 8.16.6. Business Performance

      • 8.16.7. Key Strategic Moves and Developments

    • 8.17. DuPont

      • 8.17.1. Company Overview

      • 8.17.2. Key Executives

      • 8.17.3. Company Snapshot

      • 8.17.4. Operating Business Segments

      • 8.17.5. Product Portfolio

      • 8.17.6. Business Performance

      • 8.17.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL ELASTOMERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL MEDICAL ELASTOMERS MARKET FOR THERMOSET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL MEDICAL ELASTOMERS MARKET FOR THERMOPLASTIC, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL MEDICAL ELASTOMERS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL MEDICAL ELASTOMERS MARKET FOR MEDICAL TUBES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL MEDICAL ELASTOMERS MARKET FOR CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL MEDICAL ELASTOMERS MARKET FOR SYRINGES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL MEDICAL ELASTOMERS MARKET FOR GLOVES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL MEDICAL ELASTOMERS MARKET FOR MEDICAL BAGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL MEDICAL ELASTOMERS MARKET FOR IMPLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL MEDICAL ELASTOMERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL MEDICAL ELASTOMERS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA MEDICAL ELASTOMERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 17. U.S. MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. U.S. MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. CANADA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 20. CANADA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 21. MEXICO MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. MEXICO MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. EUROPE MEDICAL ELASTOMERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. EUROPE MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. EUROPE MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. FRANCE MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 27. FRANCE MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. GERMANY MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 29. GERMANY MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. ITALY MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. ITALY MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. SPAIN MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 33. SPAIN MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. UK MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. UK MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. RUSSIA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. RUSSIA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. REST OF EUROPE MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 39. REST OF EUROPE MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. ASIA-PACIFIC MEDICAL ELASTOMERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 41. ASIA-PACIFIC MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 42. ASIA-PACIFIC MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. CHINA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. CHINA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. JAPAN MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 46. JAPAN MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. INDIA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 48. INDIA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. SOUTH KOREA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. SOUTH KOREA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. AUSTRALIA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 52. AUSTRALIA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. THAILAND MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. THAILAND MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. MALAYSIA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. MALAYSIA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. INDONESIA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. INDONESIA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. REST OF ASIA PACIFIC MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. REST OF ASIA PACIFIC MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. LAMEA MEDICAL ELASTOMERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 62. LAMEA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 63. LAMEA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. BRAZIL MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 65. BRAZIL MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH AFRICA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH AFRICA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. SAUDI ARABIA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 69. SAUDI ARABIA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. UAE MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 71. UAE MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. ARGENTINA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 73. ARGENTINA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. REST OF LAMEA MEDICAL ELASTOMERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. REST OF LAMEA MEDICAL ELASTOMERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. TRELLEBORG AB: KEY EXECUTIVES
  • TABLE 77. TRELLEBORG AB: COMPANY SNAPSHOT
  • TABLE 78. TRELLEBORG AB: OPERATING SEGMENTS
  • TABLE 79. TRELLEBORG AB: PRODUCT PORTFOLIO
  • TABLE 80. TRELLEBORG AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. KURARAY CO., LTD.: KEY EXECUTIVES
  • TABLE 82. KURARAY CO., LTD.: COMPANY SNAPSHOT
  • TABLE 83. KURARAY CO., LTD.: OPERATING SEGMENTS
  • TABLE 84. KURARAY CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 85. KURARAY CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. TEKNOR APEX: KEY EXECUTIVES
  • TABLE 87. TEKNOR APEX: COMPANY SNAPSHOT
  • TABLE 88. TEKNOR APEX: OPERATING SEGMENTS
  • TABLE 89. TEKNOR APEX: PRODUCT PORTFOLIO
  • TABLE 90. TEKNOR APEX: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. MOMENTIVE PERFORMANCE MATERIALS INC.: KEY EXECUTIVES
  • TABLE 92. MOMENTIVE PERFORMANCE MATERIALS INC.: COMPANY SNAPSHOT
  • TABLE 93. MOMENTIVE PERFORMANCE MATERIALS INC.: OPERATING SEGMENTS
  • TABLE 94. MOMENTIVE PERFORMANCE MATERIALS INC.: PRODUCT PORTFOLIO
  • TABLE 95. MOMENTIVE PERFORMANCE MATERIALS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. CELANESE CORPORATION: KEY EXECUTIVES
  • TABLE 97. CELANESE CORPORATION: COMPANY SNAPSHOT
  • TABLE 98. CELANESE CORPORATION: OPERATING SEGMENTS
  • TABLE 99. CELANESE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 100. CELANESE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. POLYONE CORPORATION: KEY EXECUTIVES
  • TABLE 102. POLYONE CORPORATION: COMPANY SNAPSHOT
  • TABLE 103. POLYONE CORPORATION: OPERATING SEGMENTS
  • TABLE 104. POLYONE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 105. POLYONE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. KRATON CORPORATION: KEY EXECUTIVES
  • TABLE 107. KRATON CORPORATION: COMPANY SNAPSHOT
  • TABLE 108. KRATON CORPORATION: OPERATING SEGMENTS
  • TABLE 109. KRATON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 110. KRATON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. RAUMEDIC AG: KEY EXECUTIVES
  • TABLE 112. RAUMEDIC AG: COMPANY SNAPSHOT
  • TABLE 113. RAUMEDIC AG: OPERATING SEGMENTS
  • TABLE 114. RAUMEDIC AG: PRODUCT PORTFOLIO
  • TABLE 115. RAUMEDIC AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. HEXPOL AB: KEY EXECUTIVES
  • TABLE 117. HEXPOL AB: COMPANY SNAPSHOT
  • TABLE 118. HEXPOL AB: OPERATING SEGMENTS
  • TABLE 119. HEXPOL AB: PRODUCT PORTFOLIO
  • TABLE 120. HEXPOL AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. FOSTER CORPORATION: KEY EXECUTIVES
  • TABLE 122. FOSTER CORPORATION: COMPANY SNAPSHOT
  • TABLE 123. FOSTER CORPORATION: OPERATING SEGMENTS
  • TABLE 124. FOSTER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 125. FOSTER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 126. RTP COMPANY: KEY EXECUTIVES
  • TABLE 127. RTP COMPANY: COMPANY SNAPSHOT
  • TABLE 128. RTP COMPANY: OPERATING SEGMENTS
  • TABLE 129. RTP COMPANY: PRODUCT PORTFOLIO
  • TABLE 130. RTP COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 131. THE HYGENIC CORPORATION: KEY EXECUTIVES
  • TABLE 132. THE HYGENIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 133. THE HYGENIC CORPORATION: OPERATING SEGMENTS
  • TABLE 134. THE HYGENIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 135. THE HYGENIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 136. BIOMERICS: KEY EXECUTIVES
  • TABLE 137. BIOMERICS: COMPANY SNAPSHOT
  • TABLE 138. BIOMERICS: OPERATING SEGMENTS
  • TABLE 139. BIOMERICS: PRODUCT PORTFOLIO
  • TABLE 140. BIOMERICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 141. DSM: KEY EXECUTIVES
  • TABLE 142. DSM: COMPANY SNAPSHOT
  • TABLE 143. DSM: OPERATING SEGMENTS
  • TABLE 144. DSM: PRODUCT PORTFOLIO
  • TABLE 145. DSM: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 146. BASF SE: KEY EXECUTIVES
  • TABLE 147. BASF SE: COMPANY SNAPSHOT
  • TABLE 148. BASF SE: OPERATING SEGMENTS
  • TABLE 149. BASF SE: PRODUCT PORTFOLIO
  • TABLE 150. BASF SE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 151. DOW: KEY EXECUTIVES
  • TABLE 152. DOW: COMPANY SNAPSHOT
  • TABLE 153. DOW: OPERATING SEGMENTS
  • TABLE 154. DOW: PRODUCT PORTFOLIO
  • TABLE 155. DOW: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 156. DUPONT: KEY EXECUTIVES
  • TABLE 157. DUPONT: COMPANY SNAPSHOT
  • TABLE 158. DUPONT: OPERATING SEGMENTS
  • TABLE 159. DUPONT: PRODUCT PORTFOLIO
  • TABLE 160. DUPONT: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL ELASTOMERS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MEDICAL ELASTOMERS MARKET
  • FIGURE 3. SEGMENTATION MEDICAL ELASTOMERS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MEDICAL ELASTOMERS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMEDICAL ELASTOMERS MARKET
  • FIGURE 11. MEDICAL ELASTOMERS MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. MEDICAL ELASTOMERS MARKET FOR THERMOSET, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. MEDICAL ELASTOMERS MARKET FOR THERMOPLASTIC, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. MEDICAL ELASTOMERS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. MEDICAL ELASTOMERS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 16. MEDICAL ELASTOMERS MARKET FOR MEDICAL TUBES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. MEDICAL ELASTOMERS MARKET FOR CATHETERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. MEDICAL ELASTOMERS MARKET FOR SYRINGES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. MEDICAL ELASTOMERS MARKET FOR GLOVES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. MEDICAL ELASTOMERS MARKET FOR MEDICAL BAGS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. MEDICAL ELASTOMERS MARKET FOR IMPLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. MEDICAL ELASTOMERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 27. COMPETITIVE DASHBOARD
  • FIGURE 28. COMPETITIVE HEATMAP: MEDICAL ELASTOMERS MARKET
  • FIGURE 29. Top player positioning, 2022
  • FIGURE 30. TRELLEBORG AB: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. TRELLEBORG AB: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. TRELLEBORG AB: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. KURARAY CO., LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. KURARAY CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. KURARAY CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. TEKNOR APEX: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. TEKNOR APEX: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. TEKNOR APEX: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. MOMENTIVE PERFORMANCE MATERIALS INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. MOMENTIVE PERFORMANCE MATERIALS INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. MOMENTIVE PERFORMANCE MATERIALS INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. CELANESE CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. CELANESE CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. CELANESE CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. POLYONE CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. POLYONE CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. POLYONE CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. KRATON CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. KRATON CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. KRATON CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. RAUMEDIC AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. RAUMEDIC AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. RAUMEDIC AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. HEXPOL AB: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. HEXPOL AB: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. HEXPOL AB: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. FOSTER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. FOSTER CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. FOSTER CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. RTP COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. RTP COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. RTP COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. THE HYGENIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. THE HYGENIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. THE HYGENIC CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 66. BIOMERICS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. BIOMERICS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 68. BIOMERICS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 69. DSM: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 70. DSM: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 71. DSM: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 72. BASF SE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 73. BASF SE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 74. BASF SE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 75. DOW: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 76. DOW: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 77. DOW: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 78. DUPONT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 79. DUPONT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 80. DUPONT: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Medical Elastomers Market

Start reading.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers